Business Description
Nkarta is a South San Francisco-based medical company focused on developing treatments that use natural killer cells to fight cancer and autoimmune conditions. Its main therapy, NKX019, is currently being tested in early-stage clinical trials for several serious immune disorders, including lupus and related conditions. Founded in 2015, the company works alongside CRISPR Therapeutics to advance its research.
